Stocks and Investing Stocks and Investing
Fri, June 14, 2024
Thu, June 13, 2024

Yasmeen Rahimi Initiated (BNTC) at Buy and Held Target at $30 on, Jun 13th, 2024


Published on 2024-10-28 11:56:09 - WOPRAI, Yasmeen Rahimi
  Print publication without navigation


Yasmeen Rahimi of Piper Sandler, Initiated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $30 on, Jun 13th, 2024.

Yasmeen has made no other calls on BNTC in the last 4 months.



There is 1 other peer that has a rating on BNTC. Out of the 1 peers that are also analyzing BNTC, 0 agree with Yasmeen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Yasmeen


  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Increased Target to $16 on, Monday, April 22nd, 2024
Contributing Sources